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Abstract  
Objective: Objective of study was to assess the inflammation in obstructive sleep apnea syndrome patients by 
using platelet lymphocyte ratio and relationship between platelet lymphocyte ratio and severity of obstructive 
sleep apnea.  
Study Design: Cross sectional study 
Place and Duration: Pulmonology department of Nishtar Hospital Multan and Jinnah Hospital, Lahore  from 
June 2018 to March 2019. 
Methods: This cross sectional study was conducted in Pulmonology department of Nishtar Hospital Multan from 
June 2016 to March 2017.Total 280 patients were selected by non-probability consecutive sampling. All patients 
underwent whole night polysomnography. Patients were divided into control group (AHI <5), mild OSAS group 
(AHI 5-15), moderate OSAS group (AHI 15-30) and sever OSAS group (AHI >30) according to their AHI score. 
Numerical variables like age, body mass index, white cell count, platelets, hemoglobin (Hb) and platelet 
lymphocyte ratio were statistically analyzed by mean and standard deviation and t-test applied to assess their 
significance. Qualitative variables like gender and smoking status were statistically analyzed by frequency and 
percentage. Chi square test was applied to check the significance. P value <0.05 was regarded as significant. 
Results: Platelet lymphocyte ratio was significantly raised in patients with obstructive sleep apnea syndrome. 
There was significant correlation between platelet lymphocyte ratio and AHI (p<0.05). So study showed that 
there was significant association between obstructive sleep apnea syndrome severity (represented by AHI) and 
systemic inflammation (represented by PLR). Significant differences were found between age (p =0.000), ESR 
(p =0.000), CRP (p =0.003), Cholesterol (p =0.000), Platelets (p =0.048), Hb (p =0.000), PLR (p =0.000) and 
white blood cells (p =0.000), in groups. Association was found between gender (p =0.000) and smoking status (p 
=0.030) in groups. So, gender and smoking were the effect modifiers. 
Conclusion: the observations of our study suggest that Platelet lymphocyte ratio was significantly raised in 
patients with obstructive sleep apnea syndrome. There was significant correlation between platelet lymphocyte 
ratio and AHI (p<0.05). So study showed that there was significant association between obstructive sleep apnea 
syndrome severity (represented by AHI) and systemic inflammation (represented by PLR).  
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Introduction: 
Obstructive sleep apnea syndrome (OSAS) is very common sleep disorder {1}. Snoring is most common 
symptom of obstructive sleep apnea syndrome. It affects 7% of women and 20% of men in whole population 
{1}. It is one of the bigger health problem of adults. Upper airway collapse during sleep results in recurring 
apnea, disturbed sleep, excessive daytime sleepiness and intermittent hypoxia {2}. Most occurring nocturnal 
symptoms of obstructive sleep apnea syndrome are snoring and observed apneas. Disruption of normal sleep 
pattern and ventilation results in many complications through various pathophysiology. Obstructive sleep apnea 
syndrome patients suffer impaired quality of life and decrease performance status {1}. Several factors have been 
considered for development of obstructive sleep apnea syndrome. Obesity is one of major risk factor for 
developing obstructive sleep apnea syndrome {3}. It is reported that 70% patients of obstructive sleep apnea 
syndrome are obese {3}. Other risk factors are alcohol consumption, smoking, chronic pain and chronic opioid 
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therapy {4}. This disorder develops due to reduction of the expansion forces of the pharyngeal dilator muscles, 
as it occurs in genioglossal muscle dysfunction and discoordination between the respiratory effort and 
inspiratory activity of the muscle. It is also reported that obstructive sleep apnea syndrome is associated with 
vitamin D deficiency {5}. Obstructive sleep apnea syndrome is contributing factor for many diseases. It is 
associated with cardiovascular diseases, neurological diseases and metabolic diseases {6}. So physicians should 
properly investigate and address this issue.  
Many studies have shown that systemic inflammation, endothelial damage, oxidative stress, and increased 
coagulation factors in patients of obstructive sleep apnea syndrome are caused by many factors {7}. White blood 
cells and its subtypes are recognized inflammatory markers {8}. One of this is neutrophil-lymphocyte ratio 
(NLR). The rationale of this is because in inflammation there is decrease in lymphocytes count and increase in 
neutrophils count, so the ratio of these two can be used as marker of inflammation. Recent studies have shown 
platelet-lymphocyte ratio another inflammatory marker, that can predict adverse outcome in cardio vascular 
diseases {9}. Because platelet count is indicator of severity of inflammation. Pro-inflammatory cytokines 
stimulate the megakaryocytes that result in thrombocytosis {10}. 
 Like NLR, platelet lymphocyte ratio (PLR) is also associated with mortality of acute myocardial infarction 
{11}. But data is lacking about the association of inflammation in obstructive sleep apnea syndrome patients and 
platelet lymphocyte ratio. We want to investigate the issue in our region. So that it can help to establish the 
relationship between platelet lymphocyte ratio and severity of obstructive sleep apnea syndrome. It will also 
provide base for further research on this topic in coming days. Study done by Yeo-Jeong Song Et al. was taken 
as reference study {20}. 
Methods and materials: 
This cross sectional study was conducted in Pulmonology department of Nishtar Hospital Multan and Jinnah 
Hospital, Lahore  from June 2018 to March 2019.after approval of the study was taken from institutional ethical 
committee. Written permission was taken from all patients enrolled in study. Total 280 patients were selected by 
non-probability consecutive sampling. Patients with following disorders were excluded: 1) patients with history 
of any systemic disease like liver disease 2) history of secondary hypertension 3) complaint of respiratory 
infection and failure 4) central nervous system disorders 5) any history of malignancy 6) having critical illness 
with poor functional status 7)history of heart failure and acute coronary syndrome or having myocardial 
infarction or any revascularization procedure. Sample size of the study calculated by a reference study done by 
Yeo-Jeong Song Et al. For which confidence interval was taken as 95 %, power of study 80, odd ratio of platelet 
lymphocyte ratio was 3.37 (www.openepi.com). 
All patients participated in study were enrolled from outpatient department. Patients who presented with history 
of fatigue, day time sleepiness, snoring and disturbed sleep were selected. Patients who had high malampati 
score and short neck and also having history of disturbed sleep and snoring were also selected. A detailed 
physical examination was conducted in each patient to investigate the features of obstructive sleep apnea 
syndrome, its complications and also any clues of other systemic disease. All patients with normal renal status 
and age between 18 to 80 were include. During first visit demographic variables like age, gender, weight, height, 
income, medication history and other diseases were recorded. All patients underwent polysomnography. 
The system of polysomnography contains four channels of electroencephalogram and two channels of 
electrooculography, submental electromyography(EMG), pulse oximeter for recording oxygen saturation, 
thoracic and abdominal movements, electrocardiogram, tracheal sound and oronasal air flow. A complete 
cessation in airflow for more than 10s was taken as apnea. Air flow reduction >30% for greater than 10s with 4 
% decrease in oxygen saturation of patient was defined as hypopnea. {12}. Severity of obstructive sleep apnea 
was calculated by apnea hypopnea index. Apnea hypopnea index is number of events of apnea and hypopnea per 
hour during sleep. All patients were divided into four groups according to their apnea hypopnea index scores: 1) 
the control group with AHI <5, 2) mild OSAS group with AHI 5–15, 3) moderate OSAS group with AHI 16–30, 
and 4) severe OSAS group with AHI score >30. 
Complete blood count was analyzed along with serum glucose, cholesterol, erythrocyte sediment rate and c 
reactive protein. Platelet lymphocyte ratio was calculated by dividing lymphocytes from platelets.  
Data was analyzed by SPSS volume 23. Numerical variables like age, body mass index, white cell count, 
platelets, hemoglobin (Hb) and platelet lymphocyte ratio were statistically analyzed by mean and standard 
deviation and t-test applied to assess their significance. Qualitative variables like gender and smoking status 
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were statistically analyzed by frequency and percentage. Chi square test was applied to check the significance. P 
value <0.05 was regarded as significant. 
Results: 
 Overall, 100% (n=280) patients were enrolled in this study; divided according to OSAS status i.e. 
control group (n=63), mild OSAS group (n=60), moderate group (n=67) and severe OSAS group (n=90). The 
mean age and BMI of the control group patients was 45.22±2.57 years and 23.90±2.66 kg/m2 respectively. There 
were 57.1% (n=36) males and 42.9% (n=27) females. Smoking status showed that there were 87.3% (n=55) non-
smokers and 12.7% (n=8) were smokers. The mean age and BMI of the Mild OSAS group patients was 
49.85±2.11 years and 24.03±2.74 kg/m2 respectively. There were 76.7% (n=46) males and 23.3% (n=14) 
females. Smoking status showed that there were 90% (n=54) non-smokers and 10% (n=6) were smokers. The 
mean age and BMI of the moderate OSAS group patients was 50.37±2.28 years and 27.00±3.03 kg/m2 
respectively. There were 89.6% (n=60) males and 10.4% (n=7) females. Smoking status showed that there were 
74.6% (n=50) non-smokers and 25.4% (n=17) were smokers. The mean age and BMI of the severe OSAS group 
patients was 52.34±2.60 years and 26.54±2.66 kg/m2 respectively. There were 82.2% (n=74) males and 17.8% 
(n=16) females. Smoking status showed that there were 74.4% (n=67) non-smokers and 25.6% (n=23) were 
smokers. (Table. 1). 
 The mean ESR, CRP, cholesterol, platelets, lymphocytes, Hb, PLR and WBC of the control patients 
was 8.01±2.27 mm/hr, 0.63±0.35 mg/L, 170.21±11.88 mg/dl, 221.35±12.11×109/L, 36.25±5.00 %, 12.95±1.30 
g/dl, 98.80±7.69 and 6760.23±14.10 ×106/L respectively. The mean ESR, CRP, cholesterol, platelets, 
lymphocytes, Hb, PLR and WBC of the mild OSAS patients was 18.25±2.29 mm/hr, 1.31±0.85 mg/L, 
185.72±5.58 mg/dl, 225.23±5.88 ×109/L, 35.20±2.66 %, 15.26±2.14 g/dl, 114.90±2.13 and 7287.03±24.08 
×106/L respectively. The mean ESR, CRP, cholesterol, platelets, lymphocytes, Hb, PLR and WBC  of the 
moderate OSAS patients was 17.71±9.27 mm/hr, 0.78±0.33 mg/L, 190.42±11.21 mg/dl, 230.96±4.69 ×109/L, 
31.88±4.37 %, 13.01±2.08 g/dl, 121.63±5.53 and 7314.83±23.36 ×106/L respectively. The mean ESR, CRP, 
cholesterol, platelets, lymphocytes, Hb, PLR and WBC  of the severe OSAS patients was 14.38±3.80 
mm/hr, 1.72±1.47 mg/L, 175.34±5.90 mg/dl, 254.01±10.78 ×109/L, 28.24±4.96 %, 14.06±1.14 g/dl, 
141.60±19.83 and 7720.83±27.44 ×106/L respectively. (Table. 2). 
 Significant differences were found between age (p =0.000), ESR (p =0.000), CRP (p =0.003), 
Cholesterol (p =0.000), Platelets (p =0.048), Hb (p =0.000), PLR (p =0.000) and white blood cells (p =0.000), in 
groups. Association was found between gender (p =0.000) and smoking status (p =0.030) in groups. So, gender 
and smoking were the effect modifiers. (Table. 1-2). 
Table. 1 
Demographic Variables 
 
Variable 
Control group 
n=(63) 
Mild OSAS 
group 
n=(60) 
Moderate 
OSAS group 
n=(67) 
Severe OSAS 
group n=(90) Test of Sig. 
Age 
45.22±2.57 
years 
49.85±2.11 
years 
50.37±2.28 
years 
52.34±2.60 
years 
F=3.95 
p=0.000 
BMI 
23.90±2.66 
kg/m2 
24.03±2.74 
kg/m2 
27.00±3.03 
kg/m2 
26.54±2.66 
kg/m2 
F=1.25 
p=0.175 
Gender 
M=57.1%, 
F=42.9% 
M=76.7%, 
F=23.3% 
M=89.6%, 
F=10.4% 
M=82.2%, 
F=17.8% 
χ2=21.47, 
p=0.000 
Smoking 
Status 
Non-
smoker=87.3%, 
Smoker=12.7% 
Non-
smoker=90%, 
Smoker=10% 
Non-
smoker=74.6%, 
Smoker=25.4% 
Non-
smoker=74.4%, 
Smoker=25.6% 
χ2=8.95 
,p=0.030 
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Table. 2 
Hematological Parameters Association with Obstructive Sleep Apnea Syndrome.  
Variable 
Control group 
n=(63) 
Mild OSAS 
group 
n=(60) 
Moderate 
OSAS group 
n=(67) 
Severe OSAS 
group n=(90) Test of Sig. 
ESR, 
mm/hour 
8.01±2.27 18.25±2.29 17.71±9.27 14.38±3.80 F=5.21, 
p=0.000 
CRP, mg/L 
0.63±0.35 1.31±0.85 0.78±0.33 1.72±1.47 F=1.92, 
p=0.003 
Cholesterol, 
mg/dl 
170.21±11.88 185.72±5.58 190.42±11.21 175.34±5.90 F=3.49 
,p=0.000 
Platelets, 
109/L 
221.35±12.11 225.23±5.88 230.96±4.69 254.01±10.78 F=1.49 
,p=0.048 
Lymphocytes, 
% 
36.25±5.00 35.20±2.66 31.88±4.37 28.24±4.96 F=1.39, 
p=0.085 
Hb, g/dl 
12.95±1.30 15.26±2.14 13.01±2.08 14.06±1.14 F= 2.71, 
p=0.000 
PLR 
98.80±7.69 114.90±2.13 121.63±5.53 141.60±19.83 F=2.59, 
p=0.000 
WBC, 106/L 
6760.23±14.10 7287.03±24.08 7314.83±23.36 7720.83±27.44 F=4.81, 
p=0.000 
 
Discussion 
Study was concluded with two main findings. One, that platelet lymphocyte ratio, an inflammatory marker, was 
significantly raised in obstructive sleep apnea syndrome patients. Second, there was significant correlation 
between platelet lymphocyte ratio and AHI (p<0.05). So study showed a significant association between 
obstructive sleep apnea syndrome severity (represented by AHI) and systemic inflammation (represented by 
PLR). 
Previous studies had shown that there is association of elevated platelet counts with poor outcome of 
cardiovascular (CV) diseases. {13-14}. And also there is association of lower lymphocytes count with higher 
mortality and morbidity of cardiovascular diseases {14}. So combination of these two markers have emerged as 
potential inflammatory marker and outcome predictor in many malignant diseases and cardio vascular diseases 
{15-16}. It has been also reported that platelet lymphocyte ratio is predictor of long term and in hospital 
mortality in patients with STEMI and non-STEMI {17-18}.  
Platelets can interact with many inflammatory cells like dendritic cell, neutrophils, T-lymphocytes, mono-
nuclear phagocytes and can also interact with endothelial cells. The relation between these cells and platelets 
might initiate the inflammation. Previous studied reported that activated platelets could initiate inflammation by 
recruitment of white blood cells. 
Obstructive sleep apnea syndrome is not simple disorder that occurs during sleep. Multiple studies had shown 
that obstructive sleep apnea syndrome patients have increased levels of inflammatory markers compared to 
matched controls and after using continuous positive airway pressure as treatment, significant decrease in these 
markers occur {19}. 
Previous study also reported results that are equivocal to our study and these results show that there is significant 
association between platelet lymphocyte ratio and severity of obstructive sleep apnea syndrome {20}. In this 
study there was also significant correlation between higher age and body mass index with higher AHI index. 
Another study also supports this investigation with results that increased systemic inflammation assessed by 
platelet lymphocyte ratio with severity of obstructive sleep apnea syndrome {21}. 
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In past there were conflicting reports about association of upper airway obstruction and inflammatory markers 
{22-23}. Korkmaz M.et al. {22} reported that severity of systemic inflammation cannot be predicted by other 
traditional markers like C-reactive protein and ESR.  
Explanation to the relationship between inflammation and severity of obstructive sleep apnea syndrome is sleep 
deprivation and intermittent hypoxia. Many reports had shown that obstructive sleep apnea syndrome develop 
inflammatory response and high level of inflammatory mediators like coagulation factor, inter cellular adhesion 
molecules (ICAM) and CRP {24}. 
Calculation of platelet lymphocyte ratio is very cheap and easy method as compared to other mediators like 
interleukins (IL-6, IL-1b) and TNF-alpha. Study results showed that inflammation in obstructive sleep apnea 
syndrome patients can be predicted by platelet lymphocyte ratio. So this inexpensive and easy procedure should 
be adopted by pulmonologists to assess the inflammation in patients of obstructive sleep apnea syndrome on first 
stage. 
Limitation of the study was that sample size was very small relatively and other inflammatory markers like ESR 
and CRP were not compared with platelet lymphocyte ratio. 
Conclusion: 
Platelet lymphocyte ratio was significantly raised in patients with obstructive sleep apnea syndrome. There was 
significant correlation between platelet lymphocyte ratio and AHI (p<0.05). So study showed that there was 
significant association between obstructive sleep apnea syndrome severity (represented by AHI) and systemic 
inflammation (represented by PLR). 
Recommendations: 
New inflammatory markers are required to investigate the level of systemic inflammation in obstructive sleep 
apnea syndrome patients. Platelet lymphocyte ratio, an easy, quick and cheap measurable marker on routine 
CBC analysis, could be considered for assessing the inflammation in obstructive sleep apnea syndrome patients. 
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